Fig. (1).
Maximum improvement in UPDRS motor score following treatment with ABT-431 or levodopa in patients with PD [39]. *P < 0.05; †P < 0.005, compared with placebo. PD, Parkinson’s disease; UPDRS, Unified Parkinson’s Disease Rating Scale.
Maximum improvement in UPDRS motor score following treatment with ABT-431 or levodopa in patients with PD [39]. *P < 0.05; †P < 0.005, compared with placebo. PD, Parkinson’s disease; UPDRS, Unified Parkinson’s Disease Rating Scale.